| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2006;48:1095.)
© 2006 American Heart Association, Inc.
Original Articles |
From the Department of Medicine (K.M., Y.W., R.E.P., V.J.D.), Duke University Medical Center, Durham NC; and Cardiovascular Research Laboratories (K.M., Y.W., Y.O., R.E.P.), Brigham and Womens Hospital, Harvard Medical School, Boston, Mass.
Correspondence to Victor J. Dzau, Office of the Chancellor, Duke University Medical Center, Durham, NC 27710. E-mail victor.dzau{at}duke.edu
Clinical and experimental evidence suggest that the reninangiotensin system (RAS) plays a role in metabolic syndrome. Adipogenesis is suggested to modulate obesity and obesity-related consequences, such as metabolic syndrome. Although mesenchymal stem cells (MSCs) are a major source of adipocyte generation, the influence of RAS on MSC differentiation to adipocyte is unknown. We evaluated the expression of endogenous RAS in human MSCs during its differentiation to adipocytes and studied the effects of angiotensin II (Ang II), Ang II type 1 receptor blocker Valsartan, and type 2 (AT2) receptor blocker PD123319. Our data showed that differentiation was associated with an increase in cellular renin and AT2 receptor expression and a concomitant decrease in angiotensinogen and angiotensin-converting enzyme expression. The net effect is an increase in endogenous cellular angiotensin II production. Incubation with Ang II (exogenous) inhibited adipogenesis. Combined treatment of exogenous Ang II and Valsartan further inhibited adipogenesis, whereas combined treatment of Ang II and PD123319 completely abolished the inhibition of adipogenesis, suggesting an important role for the AT2 receptor. Blockade of endogenous angiotensin II effect by incubation with Valsartan alone inhibited adipogenesis, whereas PD123319 alone promoted adipogenesis, confirming the data using exogenous Ang II. The combination of Valsartan and PD123319 had no net effect. Our data demonstrate an important role of the expression of the local RAS in the regulation of human MSC differentiation to adipocytes. Elucidation of the molecular mechanism should provide important insight into the pathophysiology of the metabolic syndrome and the development of future therapeutics.
Key Words: reninangiotensin system angiotensin II mesenchymal stem cells gene expression adipose tissue obesity
Related Article:
Hypertension 2006 48: 1020-1022.
This article has been cited by other articles:
![]() |
M. Gupte, C. M. Boustany-Kari, K. Bharadwaj, S. Police, S. Thatcher, M. C. Gong, V. L. English, and L. A. Cassis ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R781 - R788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mogi, M. Iwai, and M. Horiuchi Emerging Concept of Adipogenesis Regulation by the Renin-Angiotensin System Hypertension, December 1, 2006; 48(6): 1020 - 1022. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |